These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4791683)

  • 21. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of systemic availability from plasma-level data after oral drug administration.
    Perrier D; Gibaldi M; Boyes RN
    J Pharm Pharmacol; 1973 Mar; 25(3):256-7. PubMed ID: 4146327
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: The line-up on bioavailability.
    Schneller GH
    Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-effect curves and relative biophasic drug levels: elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response.
    Weigand WA; Jhawar AK
    J Pharmacokinet Biopharm; 1976 Feb; 4(1):67-80. PubMed ID: 1271241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Differences in drug pharmacokinetics and effects upon oral versus parenteral administration. Review with special interest in first-pass effect on the liver].
    Morland J
    Tidsskr Nor Laegeforen; 1976 Mar; 96(9-10):554-8. PubMed ID: 1258025
    [No Abstract]   [Full Text] [Related]  

  • 26. Biopharmaceutics and applied pharmacy.
    Krówczyński L
    Pharmazie; 1971 Nov; 26(11):659. PubMed ID: 5154316
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.
    Wagner JG
    Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857
    [No Abstract]   [Full Text] [Related]  

  • 28. Biopharmaceutics. I. Factors influencing drug distribution in the body. Penetration of drugs through biological membranes--storage and elimination--factors influencing routes of drug administration.
    Doluisio JT; Swintosky JV
    Am J Pharm Sci Support Public Health; 1965; 137(4):144-68. PubMed ID: 5826566
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral biopharmaceutics-current status and identified gaps of understanding.
    Lennernäs H; Abrahamsson P; Langguth B
    Eur J Pharm Sci; 2014 Jun; 57():98. PubMed ID: 24508580
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 31. Calculation of absorption rate constants for drugs with incomplete availability.
    Perrier D; Gibaldi M
    J Pharm Sci; 1973 Feb; 62(2):225-8. PubMed ID: 4686394
    [No Abstract]   [Full Text] [Related]  

  • 32. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biopharmacy and pharmacokinetics].
    Janků I
    Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
    [No Abstract]   [Full Text] [Related]  

  • 35. Route of administration and drug disposition.
    Gibaldi M; Perrier D
    Drug Metab Rev; 1974; 3(2):185-99. PubMed ID: 4607867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects.
    Heimlich KR
    J Pharm Sci; 1972 Oct; 61(10):1686-9. PubMed ID: 5072432
    [No Abstract]   [Full Text] [Related]  

  • 39. Formulations and dosages of oral drugs.
    Calesnick B
    Am Fam Physician; 1978 Sep; 18(3):160-2. PubMed ID: 685796
    [No Abstract]   [Full Text] [Related]  

  • 40. Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.
    Lennernäs H
    Mol Pharm; 2014 Jan; 11(1):12-23. PubMed ID: 24206063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.